Eli Lilly Faces Second Cymbalta Trial After Bellwether Win
Days after Eli Lilly & Co. defeated claims it concealed the withdrawal risks of its antidepressant Cymbalta in a bellwether trial, the company found itself facing off against the same attorneys...To view the full article, register now.
Already a subscriber? Click here to view full article